US FDA Announces Class I Recalls For Integra, Edwards Surgical Devices
Executive Summary
The US Food and Drug Administration announced two class I recalls on 24 May. The recalls cover Integra’s LimiTorr Volume Limiting cerebrospinal fluid (CSF) drainage system and the MoniTorr intracranial pressure external CSF drainage and monitoring systems, as well as clinical platforms in Edwards’ EV1000 series.
You may also be interested in...
Nine Best Practices For Creating And Implementing A Risk Management Plan
As regulatory scrutiny increases, device manufacturers are putting added emphasis on risk management to avoid expensive remediation, reputational damage, and, more importantly, negative impact on safety. Methodical risk management also offers many other benefits, such as information for new product development, business expansion, and improved decision-making.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.